Asclepio Medical Research entered the industry of Medical Research in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 8121910, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Mark Axelberd by calling (305) 418-9262 during business hours. You can also write to the business’ Single Location at 3900 Nw 79th Avenue # 511, Miami, Florida FL 33166. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Asclepio Medical Research |
| Representative: | Mark Axelberd |
| Place of Business: | 3900 Nw 79th Avenue # 511, Miami, FL 33166 |
| Contact Number: | (305) 418-9262 |
| Type of Service: | Medical Research |
| SIC Number: | 8733 |
| NAICS Number: | 8121910 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2010 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Asclepio Medical Research is a company operating from Miami-Dade, Florida providing professional Medical Research and relevant B2B variables. It was founded in 2010 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 8121910 as Medical Research.
With a current employee count of 1 to 4, Asclepio Medical Research has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Mark Axelberd at (305) 418-9262 for related queries, or to locate its Single Location using the coordinates 25.809357,-80.325378.
The Single Location can also be found at the street address 3900 Nw 79th Avenue # 511 in Miami, Florida 33166 and can be engaged online through the company website at , the company Twitter , and Facebook page .